Zenas BioPharma, Inc. Common Stock (ZBIO) — Defensive Interval Ratio
Zenas BioPharma, Inc. Common Stock (ZBIO) has a Defensive Interval Ratio of 1355 days as of December 2025. Defensive assets of $232.55 Million (cash $-, short-term investments $232.55 Million, receivables $-) cover 1355 days of daily cash needs of $171.64K/day. Check tangible equity quality of Zenas BioPharma, Inc. Common Stock to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Zenas BioPharma, Inc. Common Stock Defensive Interval Ratio (2023–2025)
This chart shows how Zenas BioPharma, Inc. Common Stock's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the ratio stands at 1355 days, meaning defensive assets of $232.55 Million can fund 1355 days of operations without new revenue. Also explore Zenas BioPharma, Inc. Common Stock net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Zenas BioPharma, Inc. Common Stock (2023–2025)
The table below presents the year-by-year Defensive Interval Ratio for Zenas BioPharma, Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Zenas BioPharma, Inc. Common Stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1355 days | $232.55 Million | $171.64K/day | $- | $232.55 Million | ▲ +1157 days |
| 2024 | 198 days | $31.02 Million | $156.96K/day | $- | $31.02 Million | ▲ +198 days |
| 2023 | 0 days | $0.00 | $63.72K/day | $- | $0.00 | — |